Loomis, Sayles & Company
NVO icon

Loomis, Sayles & Company’s Novo Nordisk NVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$868M Buy
12,576,031
+187,789
+2% +$13M 1.09% 20
2025
Q1
$860M Buy
12,388,242
+816,556
+7% +$56.7M 1.24% 19
2024
Q4
$995M Buy
11,571,686
+2,947,771
+34% +$254M 1.26% 18
2024
Q3
$1.03B Sell
8,623,915
-273,522
-3% -$32.6M 1.35% 18
2024
Q2
$1.27B Buy
8,897,437
+44,905
+0.5% +$6.41M 1.75% 17
2024
Q1
$1.14B Sell
8,852,532
-150,793
-2% -$19.4M 1.62% 17
2023
Q4
$931M Sell
9,003,325
-94,483
-1% -$9.77M 1.43% 18
2023
Q3
$827M Buy
9,097,808
+4,350,862
+92% +$396M 1.42% 17
2023
Q2
$768M Sell
4,746,946
-129,714
-3% -$21M 1.24% 21
2023
Q1
$776M Sell
4,876,660
-103,130
-2% -$16.4M 1.35% 21
2022
Q4
$674M Sell
4,979,790
-197,599
-4% -$26.7M 1.35% 23
2022
Q3
$516M Sell
5,177,389
-138,349
-3% -$13.8M 1.04% 28
2022
Q2
$592M Sell
5,315,738
-587,411
-10% -$65.5M 1.1% 27
2022
Q1
$656M Sell
5,903,149
-253,679
-4% -$28.2M 0.88% 33
2021
Q4
$690M Sell
6,156,828
-282,261
-4% -$31.6M 0.83% 31
2021
Q3
$618M Buy
6,439,089
+36,939
+0.6% +$3.55M 0.76% 31
2021
Q2
$536M Sell
6,402,150
-273,225
-4% -$22.9M 0.65% 32
2021
Q1
$450M Sell
6,675,375
-149,281
-2% -$10.1M 0.58% 33
2020
Q4
$477M Sell
6,824,656
-454,915
-6% -$31.8M 0.63% 34
2020
Q3
$505M Sell
7,279,571
-85,286
-1% -$5.92M 0.74% 33
2020
Q2
$482M Sell
7,364,857
-9,068,788
-55% -$594M 0.77% 33
2020
Q1
$989M Sell
16,433,645
-5,326,826
-24% -$321M 2.04% 14
2019
Q4
$1.26B Buy
21,760,471
+730,735
+3% +$42.3M 2.14% 16
2019
Q3
$1.09B Buy
21,029,736
+146,969
+0.7% +$7.6M 2.09% 17
2019
Q2
$1.07B Sell
20,882,767
-3,421
-0% -$175K 1.99% 16
2019
Q1
$1.09B Buy
20,886,188
+146,494
+0.7% +$7.66M 2.15% 16
2018
Q4
$955M Sell
20,739,694
-1,002,835
-5% -$46.2M 2.25% 17
2018
Q3
$1.02B Buy
21,742,529
+457,466
+2% +$21.6M 2.01% 15
2018
Q2
$982M Sell
21,285,063
-740,050
-3% -$34.1M 1.99% 17
2018
Q1
$1.08B Buy
22,025,113
+1,323,857
+6% +$65.2M 2.3% 10
2017
Q4
$1.11B Buy
20,701,256
+172,851
+0.8% +$9.28M 2.31% 11
2017
Q3
$988M Buy
20,528,405
+472,170
+2% +$22.7M 2.16% 9
2017
Q2
$860M Buy
20,056,235
+1,058,291
+6% +$45.4M 2.02% 13
2017
Q1
$651M Sell
18,997,944
-59,179
-0.3% -$2.03M 1.62% 20
2016
Q4
$683M Buy
19,057,123
+3,872,745
+26% +$139M 1.68% 20
2016
Q3
$632M Buy
15,184,378
+3,336,775
+28% +$139M 1.6% 19
2016
Q2
$637M Buy
11,847,603
+705,851
+6% +$38M 1.73% 14
2016
Q1
$604M Buy
11,141,752
+894,750
+9% +$48.5M 1.71% 15
2015
Q4
$595M Buy
10,247,002
+457,423
+5% +$26.6M 1.68% 15
2015
Q3
$531M Buy
9,789,579
+474,905
+5% +$25.8M 1.57% 14
2015
Q2
$510M Buy
9,314,674
+1,413,111
+18% +$77.4M 1.39% 14
2015
Q1
$422M Buy
7,901,563
+1,302,164
+20% +$69.5M 1.17% 15
2014
Q4
$279M Buy
6,599,399
+1,912,014
+41% +$80.9M 0.77% 30
2014
Q3
$223M Buy
4,687,385
+500,647
+12% +$23.8M 0.65% 34
2014
Q2
$193M Buy
4,186,738
+284,109
+7% +$13.1M 0.55% 37
2014
Q1
$178M Buy
+3,902,629
New +$178M 0.5% 44